Bafna Pharmaceuticals share news, announcements and annual reports
NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap
Bafna Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2008 on BSE, Apr 2018 on NSE
Last close ₹447.90down ₹9.10 (1.99%)BSE ₹447.90
Share price at the NSE close on 30 Oct 2026. Previous close ₹457.00.
30 Oct: open ₹457.00, high ₹457.00, low ₹447.90
52-week range of traded prices to 30 Oct 2026
₹94.77Low, 16 Mar 2026₹479.95High, 21 Oct 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,060 Cr2,105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 136.09
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 11.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 7,963
Bafna Pharmaceuticals share news and announcements
637 announcements, routine notices left out, newest first. Page 10 of 13.
Mar 2015
30 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 27, 2015, has appointed Mrs. K. Sabitha as an Additional Director (Woman ....2 Mar · Updates
Company have successfully cleared the renewal of audit process as per the guidelines issued by the Medicine and Healthcare Product Agency ....
Feb 2015
16 Feb · Limited Review for Dec 31, 2014
12 Feb · Results
2 Feb · Board meeting
To consider the un-audited financial results for the quarter ended December 31,2014.
Jan 2015
10 Jan · Shareholding Pattern For December 31, 2014
Nov 2014
19 Nov · Rating
CRISIL has upgraded the rating as CRISIL BB-/stable (Upgraded from CRISIL D) for Long Term rating & CRISIL A4+ (Upgraded from CRISIL D) for ....
Oct 2014
29 Oct · Management
Mr. R. S. Gowdhaman is appointed as the Company Secretary & Compliance Officer with effect from October 15, 2014 in place of Mr. K. Premnath who has resigned from the service of the Company.28 Oct · Change in Company Secretary & Compliance Officer
Mr. R.S. Gowdhaman is appointed as the Company Secretary & Compliance Officer with effect from October 15, 2014 in place of Mr. K. Premnath ....27 Oct · Board meeting
Among others, to consider the Un-Audited Financial Results for the Quarter ending September 30, 2014.22 Oct · Shareholding Pattern For September 30, 2014
Sep 2014
15 Sep · Disclosure of Voting Pattern - Clause 35A
10 Sep · Meeting
Aug 2014
26 Aug · Meeting
11 Aug · Limited Review for June 30, 2014
8 Aug · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 06, 2014 to September 10, 2014 (Both Days inclusive) for the purpose of Annual General Meeting to be held September 10, 2014.8 Aug · Meeting
7 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 06, 2014 to September 10, 2014 (both days ....5 Aug · Meeting
In terms of Section 108 of the Companies Act, 2013 read with Companies (Management & Administration) Rules, 2014, the Company has fixed August ....
Jul 2014
30 Jul · Board meeting
Among others, to consider the Un-Audited Financial Results for the Quarter ending 30th June, 2014.15 Jul · Shareholding Pattern For June 30, 2014
Jun 2014
4 Jun · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has not proposed dividend for the FY ended March 31, 2014.2 Jun · Board meeting
Board of Directors of the Company at its Board Meeting held on May 30, 2014, has not proposed dividend for FY ended March 31, 2014.
May 2014
19 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 30, 2014, inter alia : 1. to consider and approve audited ....
Apr 2014
19 Apr · Shareholding Pattern For March 31, 2014
Mar 2014
Feb 2014
14 Feb · Limited Review for Dec 31, 2013
13 Feb · Results
13 Feb · Results